相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Investigating the pernicious effects of heparan sulfate in serum amyloid A1 protein aggregation: a structural bioinformatics approach
G. Chandrasekhar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Binding mechanism and structural insights into the identified protein target of COVID-19 and importin-alpha with in-vitro effective drug ivermectin
Parth Sarthi Sen Gupta et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Naun Lobo-Galo et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
Nisha Muralidharan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
Umesh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
Phulen Sarma et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms
Mark Tristan J. Quimque et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300
Zhengfei Yu et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Forecasting the novel coronavirus COVID-19
Fotios Petropoulos et al.
PLOS ONE (2020)
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yu-chen Cao et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
15 drugs being tested to treat COVID-19 and how they would work
Leah Shaffer
NATURE MEDICINE (2020)
Drug targets for corona virus: A systematic review
Manisha Prajapat et al.
INDIAN JOURNAL OF PHARMACOLOGY (2020)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Flexible Hybrid Electronics: Direct Interfacing of Soft and Hard Electronics for Wearable Health Monitoring
Yasser Khan et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
Target identification and mechanism of action in chemical biology and drug discovery
Monica Schenone et al.
NATURE CHEMICAL BIOLOGY (2013)
Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme
K Ratia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Modular organization of SARS coronavirus nucleocapsid protein
CK Chang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Coronavirus 3CLpro proteinase cleavage sites:: Possible relevance to SARS virus pathology -: art. no. 72
L Kiemer et al.
BMC BIOINFORMATICS (2004)
A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6
C Oostenbrink et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)